IREN EQUITY Finance Services 2027 Quantitative Forecast

IREN Limited Ordinary Shares (IREN) Stock Price Prediction 2027

Multi-horizon algorithmic price targets, Wall Street consensus calibration, reverse-DCF growth expectations & options volatility valuation

$15.82
$-0.58 (-3.51%)
Market Close: Nov 17, 2026
1-Year Base Target
$23.03 +45.6%
Constant-P/E algorithmic trajectory
Wall St. Consensus
$56.69 Bull $62
Institutional analyst mean target
Risk-Adjusted Consensus Fair Value
$48.18 +204.7% Undervalued
Forward P/E -21.4x • PEG 4.05
AI Quant Stance
HOLD 45/100
RSI 29.5 • MACD Bearish • Downtrend

Executive Forecast Synopsis (2027)

Synthesized fundamental, multiple & technical thesis for IREN

AI Research Note

IREN Price Forecast 2027: Our AI models project that IREN stock will rise to approximately $23.03 by 2027. This represents a potential 45.6% growth from the current trading price of $15.81. The overall market sentiment for IREN is currently bullish, based on a combination of proprietary technical signals and fundamental analysis.

Fundamental Analysis: Trading with its most recent quarterly earnings growing by 42.9%. IREN shows a complex fundamental profile. Our model evaluates these metrics alongside sector peers and historical performance to derive the 2027 price target. If the company exceeds its current growth projections, there may be further upside beyond our base case scenario.

Technical Outlook: The stock is technically in a downtrend phase. The Relative Strength Index (RSI) is currently 29.5, which suggests the stock is in oversold territory. Traders should monitor key support and resistance levels closely, as a breakout or breakdown from current price consolidation will be the primary catalyst for the stock reaching the 2027 predicted target.

Quant Signal & Technical Posture

Composite equity rating reconciled with 1-year target trajectory

Score: 45.1/100
Composite Equity Stance
HOLD (Quant Score 45/100) — HOLD (+45.6% 1Y Target Upside)
Active Technical & Price Action Triggers
  • Volume showing distribution (CMF: -0.0796)
  • Recent pattern: Shortline pattern detected
  • Price near support at $15.77
MACD Regime: Bearish
Volume Tape: Distribution

IREN Trajectory & Forecast Curve

Projected price curve from spot ($15.82) across 30D–3Y horizons

Term Structure of Price Targets

Calibrated to Wall Street consensus curve

30D – 3Y
Horizon Target Price Implied Return
30 Days Near-Term $16.39 +3.6%
90 Days 1 Quarter $17.62 +11.4%
6 Months Medium-Term $19.42 +22.8%
1 Year Base Model $23.03 +45.6%
Wall Street 12M Consensus Target: $56.69

1-Year Scenario Distribution (Bull / Base / Bear)

Probability-weighted regime outcomes around the 12-month forecast horizon

Regime Matrix
Bull Case 30% Prob
$62.36 +294.3%

Best case scenario if strong fundamentals and market conditions align

Base Case 50% Prob
$23.03 +45.6%

Expected scenario based on current growth trajectory

Bear Case 20% Prob
$16.12 1.9%

Downside scenario if market headwinds or disappointing results

LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $16.39 · IV 122.1%

IREN Path Scenario ($78 Target): Simulated 5-Day Swing & LEAP Payoffs

Compare $1,639 for 100 IREN shares against risk-defined 5-day option spreads and long-dated LEAP structures.

5-DAY BULLISH SWING Liq A

Dec 18 $17 / $20 Bull Call Spread

Buy 2x $17C · Sell 2x $20C · 32d

Net Entry $190 Debit
T+5d @ +5% Move +$28 (+15%)
Max Risk / Buffer $190 Capped
5d Edge & Liquidity 0.7x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $14 / $13 Bull Put Spread

Sell 4x $14P · Buy 4x $13P · 32d

Net Entry $140 Credit
Max Credit / Yield +$140 (+53.8% RoM)
Max Risk / Buffer -16.7% Cushion ($260 Mgn)
5d Edge & Liquidity 73% PoP · Liq A
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq A

Dec 18 $18 / $15 Bear Put Spread

Buy 1x $18P · Sell 1x $15P · 32d

Net Entry $159 Debit
T+5d @ -5% Drop +$17 (+11%)
Max Risk / Buffer $159 Capped
5d Edge & Liquidity 0.8x R:R · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Fair Value & Core Fundamentals

PEG-adjusted intrinsic valuation & balance-sheet multiples

+204.7% Undervalued
Risk-Adjusted Consensus Fair Value: $48.18
Spot: $15.82

Risk-Adjusted Consensus Fair Value (85% of Wall Street target) estimates IREN fair value at $48.18 (+204.7% implied margin of safety), though its 4.05 PEG reflects a growth valuation premium.

PEG Ratio
4.05
Growth Premium
Implied Fair P/E
-65.2x
Model Growth 258.4%
Forward P/E
-21.41x
P/S Ratio (TTM)
11.09x
Rev Growth (YoY)
-5.0%
EPS Growth (YoY)
42.9%
Market Cap
$7,711M
52-Week High
$70.71
52-Week Low
$15.17

Technicals & Institutional Money Flow

Momentum oscillators, volume accumulation & key price levels

Distribution
Volume Tape: Distribution

Volume-weighted price action shows near-term supply/distribution pressure; watch support levels for stabilization.

RSI (14-Day)
29.5
Oversold
MACD Signal
Bearish
Primary Trend
Downtrend
Chaikin Money Flow
-0.080
Money Flow Index
25.5
200-Day SMA
$34.50

Options Volatility Valuation: 1-Year Target Strike Strategy

Comparing LEAP Call Implied Volatility & Breakeven against the 1-Year Model Target — Derivative Strategy Signal, NOT an Equity Stock Rating

Options Strategy Only Strategy Score: 16/100
OPTIONS STRATEGY: OVERWRITING / CREDIT SPREADS
SELL COVERED CALLS / COLLECT PREMIUM (Options Overpriced vs. Target)
This is an Options Volatility Valuation signal (comparing Call IV to 1Y target), NOT a sell rating on IREN shares.
Rich Call Premium (Write / Overwrite)
Premium Collected
$11.60/sh
Profit at 1Y Target
$3.91/sh
Option Writer ROI
+33.7%
Applicable Structures
Covered Call • Credit Spread
Why Options Are Flagged for Premium Selling: The $70 Call (Aug 2027) requires IREN to exceed $81.60 at expiration just to break even. Because the conservative constant-P/E 1Y model target is $77.69, buying out-of-the-money calls carries negative expected value (Buyers lose 33.7% even if target hits. Premium is overpriced for 101.2% move.), whereas shareholders overwriting covered calls capture rich implied volatility.
Wall St. 1Y Target
$77.69
+101.2% vs spot
Evaluated Call Strike
$70.00
Exp: Aug 20, 2027
Call Mark Premium
$11.60
30.0% of spot price
Call Buyer Breakeven
$81.60
Above 1Y base target
Delta / Implied Prob
51.2%
Option market odds
Contract Liquidity
241 OI
Vol: 3 • Oct 07

Unusual Options Flow Alert (Short-Term Derivative Tape)

Short-term institutional sweep & implied volatility anomaly monitor (distinct from long-term equity rating)

Moderate Alert (Options Flow)
Flow Alert Score
84/100
Tape Classification
Moderate Alert (Options Flow)
Unusual Volume Score
74.3
Implied Volatility Spike
+83.6%
Derivative Tape Readout: Short-Term Derivative Tape: Moderate unusual activity. Monitor closely. (Reflects options volume & IV anomalies, not a long-term stock rating.)

Frequently Asked Questions (IREN 2027 Outlook)

What is the IREN stock price prediction for 2027?

Based on our AI analysis, IREN is predicted to reach $23.03 by 2027, representing a potential 45.6% increase from the current price of $15.81.

Is IREN stock a good buy right now?

Our analysis rates IREN as a HOLD (AI Quant Score 45.1/100) based on current technical and fundamental indicators. With a projected 45.6% upside in our 1-year constant-P/E model, investors should consider their risk tolerance and investment horizon.

What is IREN 52-week high and low?

IREN has a 52-week high of $70.71 and a 52-week low of $15.17. The stock is currently trading 77.6% below its 52-week high.

What is the technical analysis for IREN?

IREN is currently in a downtrend trend. The RSI of 29.5 indicates the stock is oversold. Traders should monitor support and resistance levels for potential entry points.

Quantitative Research Disclaimer: Price predictions, reverse-DCF expectations, and options volatility strategies are generated algorithmically from historical financial data, analyst consensus estimates, and live options chains. They are provided strictly for informational and research purposes and do not constitute investment advice. Always conduct independent due diligence before executing equity or derivative transactions.